Literature DB >> 1615865

Six-year survival after coronary thrombolysis and early revascularization for acute myocardial infarction.

G J Taylor1, H W Moses, R E Katholi, C Korsmeyer, P Kolm, J T Dove, F L Mikell, J M Sutton, H A Wellons, J A Schneider.   

Abstract

Six-year follow-up was conducted in a consecutive series of 192 patients receiving thrombolytic therapy for acute myocardial infarction (AMI) with ST-segment elevation. Cardiac catheterization was performed within a day, and patients with an open infarct artery routinely had early revascularization: 99 (67%) underwent coronary bypass surgery and 18 (12%) coronary angioplasty. With this treatment strategy, 6-year cardiac mortality was 14.5%, 6% (12 patients) in hospital and 9% (16 patients) for survivors of hospitalization. Multivariate analysis showed that predictors of cardiac death among survivors of hospitalization were a closed infarct artery at catheterization (p less than 0.01), diabetes (p less than 0.01) and anterior myocardial infarction (p = 0.01). A subset of 146 patients underwent radionuclide angiography before hospital discharge; for them, predictors of mortality were a closed infarct artery at catheterization (p less than 0.01), anterior wall AMI (p = 0.02), and Killip class III to IV on admission (p less than 0.06). Left ventricular ejection fraction was not a significant predictor of mortality for this subset of patients.

Entities:  

Mesh:

Year:  1992        PMID: 1615865     DOI: 10.1016/0002-9149(92)91384-g

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  3 in total

1.  Coronary Artery Patency and Survival in Clinical Trials.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

2.  Coronary artery bypass surgery in smokers.

Authors:  E Shelley
Journal:  Heart       Date:  1996-06       Impact factor: 5.994

Review 3.  Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.

Authors:  K Ramanathan; C J Ellis; H D White
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.